EPCAM and neoplasm: The presence of CTC exhibiting different phenotypes in the same patient due to tumor heterogeneity induced Terstappen and Co. to conduct in-depth studies on CTC detection through the CellSearch® system, with a focus on discarded ones expressing no or low EpCAM [7–9].